López-Gutiérrez, F, Loricera, J, Molina-Collada, J, Gonáalez, JCN, Sánchez-Lucas, M, Moya, P, Labrador-Sánchez, E, Ferraz-Amaro, I, Blanco, R. SWITCHING FROM REFERENCE TOCILIZUMAB TO BIOSIMILAR IN GIANT CELL ARTERITIS: EFFECTIVENESS AND SAFETY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B3604. PMID:. IF:20.600(Q1/1D).

Espino-Guarch, M, Huang, SSY, Vilches, C, Prat, E, El Nahas, R, Missous, G, Bodoy, S, Sathappan, A, Al-Aghbar, MA, Mayayo, C, Olivé, M, Busquets-Rius, S, Sebastián, D, Zorzano, A, Palacin, M, van Panhuys, N, Nunes, V. Ablation of LAT2 Transporter Causes Intramuscular Glutamine Accumulation and Inhibition of Fasting-Induced Proteolysis. Journal of Cachexia Sarcopenia and Muscle. 2025; 16(3)DOI:10.1002/jcsm.13847. PMID:40546137. IF:9.100(Q1/1D).

Gutierrez-Gutierrez, G, Gomez-Ballesteros, R, Sotoca, J, Ares, A, Villaverde, R, Reyes, V, Armangue, T, Salas, E, Diaz-Abos, P, Rebollo, P, Sarmiento, M, Escobar, I, Maurino, J, Querol, L. Assessing therapeutic decisions in generalized myasthenia gravis: Study protocol. PLoS One. 2025; 20(4)DOI:10.1371/journal.pone.0322168. PMID:40261907. IF:2.600(Q2/4D).

Valls, A, Ruiz-Roldán, C, Immanuel, J, Alonso-Martín, S, Gallardo, E, Fernández-Torrón, R, Bonilla, M, Lersundi, A, Hernández-Laín, A, Domínguez-González, C, Vílchez, JJ, Iruzubieta, P, de Munain, AL, Sáenz, A. The Role of Integrin ß1D Mislocalization in the Pathophysiology of Calpain 3-Related Limb-Girdle Muscular Dystrophy. Cells. 2025; 14(6)DOI:10.3390/cells14060446. PMID:40136695. IF:5.200(Q2/3D).

Slioui, A, Tammam, G, Vanoli, F, Della Marina, A, Vohanka, S, Gilhus, NE, Moroni, I, Leite, MI, Piehl, F, Antozzi, C, Pini, J, Stascheit, F, Attarian, S, Santos, E, Verschuuren, J, Canonge, L, Garcia, J, Perriard, C, Cortés-Vicente, E, Mantegazza, R, Meisel, A, Sacconi, S. Toward European harmonization of national myasthenia gravis registries: modified Delphi procedure-based expert consensus on collectable data. Orphanet Journal of Rare Diseases. 2025; 20(1)DOI:10.1186/s13023-024-03520-3. PMID:40069719. IF:3.500(Q2/4D).

Caballero-avila, M, Martin-Aguilar, L, Pascual-Goni, E, Michael, MR, Koel-Simmelink, MJA, Hoeftberger, R, Wanschitz, J, Alonso-Jimenez, A, Armangue, T, Baars, AE, Carbayo, A, Castek, B, Collet-Vidiella, R, De Winter, J, del Real, MA, Delmont, E, Diamanti, L, Doneddu, PE, Hiew, FL, Gallardo, E, Gonzalez, A, Grinzinger, S, Horga, A, Iglseder, S, Jacobs, BC, Jauregui, A, Killestein, J, Pozza, EL, Martinez-Martinez, L, Nobile-Orazio, E, Ortiz, N, Perez-Perez, H, Poppert, KN, Ripellino, P, Roche, JC, de Rivera, FJR, Rostasy, K, Sparasci, D, Tejada-Illa, C, Teunissen, CCE, Vegezzi, E, Xucla-Ferrarons, T, Zach, F, Wieske, L, Eftimov, F, Lleixa, C, Querol, L. Long-Term Follow Up in Anti-Contactin-1 Autoimmune Nodopathy. ANNALS OF NEUROLOGY. 2025; 97(3)DOI:10.1002/ana.27142. PMID:39601182. IF:7.700(Q1/1D).

Querol, L, Dalakas, MC. The Discovery of Autoimmune Nodopathies and the Impact of IgG4 Antibodies in Autoimmune Neurology. Neurology-Neuroimmunology & Neuroinflammation. 2025; 12(1)DOI:10.1212/NXI.0000000000200365. PMID:39671536. IF:7.500(Q1/1D).

Reyes-Leiva, D, Carbayo, A, Vesperinas-Castro, A, Rojas-Garcia, R, Querol, L, Turon-Sans, J, Pla-Junca, F, Olivé, M, Gallardo, E, Pujades-Rodriguez, M, Cortés-Vicente, E. Persistent symptoms, exacerbations and drug side effects despite treatment in myasthenia gravis. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32(1)DOI:10.1111/ene.16463. PMID:39624955. IF:3.900(Q1/3D).